Your browser doesn't support javascript.
loading
A systematic review into patient reported outcomes following pancreaticoduodenectomy for malignancy.
Patel, Bhavik Y; White, Laura; Gavriilidis, Paschalis; Satyadas, Thomas; Frampton, Adam E; Pai, Madhava.
Afiliación
  • Patel BY; HPB Surgical Unit, Dept. of Surgery & Cancer, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London, W12 0HS, UK.
  • White L; HPB Surgical Unit, Dept. of Surgery & Cancer, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London, W12 0HS, UK.
  • Gavriilidis P; HPB Surgical Unit, Dept. of Surgery & Cancer, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London, W12 0HS, UK.
  • Satyadas T; Manchester Royal Infirmary, Manchester University Foundation Trust, Manchester, UK.
  • Frampton AE; HPB Surgical Unit, Royal Surrey County Hospital Foundation NHS Trust, Guildford, Surrey, GU2 7XX, UK; Dept. of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, The Leggett Building, Daphne Jackson Road, Guildford, University of Surrey, Surrey, GU2 7WG, UK; Division of Canc
  • Pai M; HPB Surgical Unit, Dept. of Surgery & Cancer, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London, W12 0HS, UK. Electronic address: madhava.pai04@imperial.ac.uk.
Eur J Surg Oncol ; 47(5): 970-978, 2021 May.
Article en En | MEDLINE | ID: mdl-33339639
ABSTRACT

BACKGROUND:

Pancreaticoduodenectomy is associated with high rates of morbidity. This combined with the psychological burden of cancer, may impact on a patient's quality of life (QoL), which can be measured by using patient-reported outcomes (PRO).

OBJECTIVE:

To perform a systematic review to evaluate the measurement of PRO after pancreaticoduodenectomy for cancer.

METHODS:

7 different databases were searched using 2 groups of search terms, one relating to pancreaticoduodenectomy, and one to PRO. Three authors screened the search results independently in a systematic manner based on predefined inclusion and exclusion criteria.

RESULTS:

27 studies, with 2173 eligible patients were included in the final analysis. Most of the included studies used validated instruments. The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire was most popular and used in 12 studies. The methodology of all included studies was also scrutinised. 12 studies were deemed to have high quality methodology according to pre-defined criteria.

CONCLUSION:

The instruments and methods used to measure PRO are variable. The quality of PRO within the available literature has improved over time, as has the number of studies measuring PRO. PRO should be measured with uniformity in future trials so that patients can be provided with more comprehensive information regarding post-operative recovery and QoL during the shared decision-making process preoperatively.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pancreaticoduodenectomía / Medición de Resultados Informados por el Paciente Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pancreaticoduodenectomía / Medición de Resultados Informados por el Paciente Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido